Literature DB >> 8133090

Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients.

B C Fries1, S Chou, M Boeckh, B Torok-Storb.   

Abstract

Using restriction analysis of polymerase chain reaction (PCR)-amplified DNA, the cytomegalovirus (CMV) envelope glycoprotein (gB and gH) genotypes were determined for virus isolates from 128 bone marrow transplant recipients with fatal or nonfatal CMV. All isolates could be assigned to one of four gB and gH genotypes previously identified by DNA sequencing studies. Isolates of gB type 1 were more commonly found to be of gH type 2, whereas gB types 2-4 were more commonly linked to gH type 1. A small frequency of recombination with gB was detected by restriction analysis of DNA from variable regions of the gp55 and gp116 domains. Multiple isolates from various sites of 29 patients were typed and, with three exceptions, the gB genotype remained constant in all isolates from a single patient. Patients who survived CMV infection more commonly shed virus of gB type 1 than those who died (P = .003). This significant difference of gB types among patient subsets is unexplained but raises the possibility that gB genotypes may serve as a marker for pathogenicity of CMV strains in marrow transplant patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8133090     DOI: 10.1093/infdis/169.4.769

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Comparative sequence analysis of US28 gene of human cytomegalovirus strains isolated from HIV-positive patients.

Authors:  Anne Goffard; Elyanne Gault; Flore Rozenberg; Nicole Moret; Didier Hober; Paul Dény
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

3.  Analysis of the variability of CMV strains in the RL11D domain of the RL11 multigene family.

Authors:  Karin Sekulin; Irene Görzer; Dorothea Heiss-Czedik; Elisabeth Puchhammer-Stöckl
Journal:  Virus Genes       Date:  2007-09-01       Impact factor: 2.332

4.  Drug-resistant herpesviruses: should we look for them?

Authors:  G Boivin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 3.267

5.  Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease.

Authors:  P C Woo; C Y Lo; S K Lo; H Siau; J S Peiris; S S Wong; W K Luk; T M Chan; W W Lim; K Y Yuen
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

6.  Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates.

Authors:  N S Lurain; K S Kapell; D D Huang; J A Short; J Paintsil; E Winkfield; C A Benedict; C F Ware; J W Bremer
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Diagnosis, gB genotype distribution and viral load of symptomatic congenitally infected CMV patients in Cuba.

Authors:  C Correa; V Kourí; L Pérez; Y Soto; C Limia
Journal:  J Perinatol       Date:  2016-06-16       Impact factor: 2.521

8.  Different cytomegalovirus glycoprotein B genotype distribution in serum and cerebrospinal fluid specimens determined by a novel multiplex nested PCR.

Authors:  David Tarragó; Carmen Quereda; Antonio Tenorio
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

9.  Strain-specific neutralization of human cytomegalovirus isolates by human sera.

Authors:  M Klein; K Schoppel; N Amvrossiadis; M Mach
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Genetic polymorphism of UL144 open reading frame of human cytomegalovirus DNA detected in colon samples from infants with Hirschsprung's disease.

Authors:  Zhi-Qin Mao; Ying Huang; Mei Sun; Qiang Ruan; Ying Qi; Rong He; Yu-Jing Huang; Yan-Ping Ma; Yao-Hua Ji; Zheng-Rong Sun; Hong Gao
Journal:  World J Gastroenterol       Date:  2007-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.